News

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer
AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...
BioPharma Dive2d
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...
AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1)
An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...
Fierce Pharma3d
AstraZeneca takes $181M hit in Syntimmune shareholder lawsuit on top of previous $130M award
For the second time in nine months, a Delaware judge has sided (PDF) with Syntimmune shareholders over AstraZeneca, granting a $181 million award. The decision comes on top of a $130 million verdict ...
AstraZeneca PLC ADR outperforms market on strong trading day
AstraZeneca PLC ADR closed 14.46% short of its 52-week high of $87.68, which the company reached on August 30th.
Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
Explore more
VOV.VN2d
AstraZeneca encouraged to build pharmaceutical manufacturing plant in Vietnam
VOV.VN - Prime Minister Pham Minh Chinh has proposed that AstraZeneca consider building a pharmaceutical manufacturing plant ...
exchange4media2d
AstraZeneca Group appoints Praveen Rao Akkinepally as Managing Director
Sanjeev Kumar Panchal has stepped down as Managing Director of AstraZeneca Group. The company has appointed Praveen Rao ...